All filters
Slidesets
Acute hepatitis A to E, diagnosis and management - Thomas Berg, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
B/F/TAF in treatment-naïve HIV-1 and HIV-1 RNA suppressed switch patients- Kirsten White, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Clinical development of ABX464, drug candidate for HIV functional cure- Jean-Marc Steens, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Reduced drug regimens- Andrea De Luca, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
What is the place of the monoclonal antibodies in the clinic- Julià Blanco, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
HBV: diagnostics, management and screening- Marion Peters, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Liver care in HIV - management of abnormal LFTs- Juan Berenguer, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HCV in 2018- Jürgen Rockstroh, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
NAFLD: diagnostics, management and screening- Juan Macías, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Fibrosis Markers and Cirrhosis management in HIV patients | Marion Peters, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Response to Sofosbuvir/Ledipasvir for 8 or 12 Weeks in HCV-Monoinfected and HIV/HCV-Coinfected Patients in Clinical Practice | Anaïs Corma
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Real-life Results of Grazoprevir/Elbasvir in HCV-Infected PWID: The Zepalive Studi | Juan Macías
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Baseline Resistance-Guided Therapy Does Not Enhance the Response to Interferon-Free Treatment of HCV Infection in Real Life | Luis M. Real
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HCV care after cure- Raffaele Bruno, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
A Comparison of Single and Multiple Tablet Regiments for the Treatment of HCV Infection Among HIV Co-Infected Individuals | Astou Thiam
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Long-Term Changes of Liver Stiffness After the Use of All Oral DAA Regimens | Nicolás Merchante
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Follow-Up of Sustained Virologic Responders with Hepatitis C/HIV Coinfection and Advanced Liver Disease | C. Soeiro
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HBV managment in HIV patients - Karine Lacombe, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program | Guranda Jikia, MD, MPH
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HBV Novel Therapies- Maria Buti, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018